Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

IMMU-14 demonstrates evidence of activity

May 31, 1996

No Comments

Approval to initiate NOVOMAb-G2 phase I studies granted by the FDA

May 31, 1996

No Comments

Encouraging results of IDEC-C2B8 trial reported

May 31, 1996

No Comments

Multikine trial commenced

May 31, 1996

No Comments

Single-chain immunotoxin targeted to the CD40 antigen effect as cytotoxic agent

May 31, 1996

No Comments

Daiwa's MGN-3 demonstrates immunotherapeutic activity

May 31, 1996

No Comments

Role of DF3 in human carcinoma and potential therapeutics

May 24, 1996

No Comments

Medarex presents MDX-210 phase I/II interim results

May 24, 1996

No Comments

ImClone, E. Merck continue cancer vaccine collaboration

May 24, 1996

No Comments

Vical, Corixa to collaborate on immunotherapeutic drugs for cancer

May 24, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Immuno-oncology, BioWorld Science
RSS

IMMU-14 demonstrates evidence of activity

Approval to initiate NOVOMAb-G2 phase I studies granted by the FDA

Encouraging results of IDEC-C2B8 trial reported

Multikine trial commenced

Single-chain immunotoxin targeted to the CD40 antigen effect as cytotoxic agent

Daiwa's MGN-3 demonstrates immunotherapeutic activity

Role of DF3 in human carcinoma and potential therapeutics

Medarex presents MDX-210 phase I/II interim results

ImClone, E. Merck continue cancer vaccine collaboration

Vical, Corixa to collaborate on immunotherapeutic drugs for cancer

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Experimental mRNA gene therapy suppresses preeclampsia in mice

Probing bidirectional cancer-autoimmune link can yield new targets

Immuno-oncology, BioWorld Science RSS

Immuno-oncology, BioWorld Science
RSS